Close Menu

NEW YORK — British molecular assay startup Biofidelity said today that it has raised £750,000 ($906,555) in seed funding.

Investors include UK-based Longwell Ventures, as well as an undisclosed multinational diagnostics firm and private investors.

Biofidelity, founded earlier this year, is developing a technology for the detection of low-frequency genetic mutations for diagnostic applications in areas including cancer and prenatal testing.   

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.